Cas:182553-05-5 4h-thieno[3,2-b]pyrrole-5-carbonyl chloride manufacturer & supplier

Chemical Name:4h-thieno[3,2-b]pyrrole-5-carbonyl chloride

CAS.NO:182553-05-5

Synonyms:4h-thieno[3,2-b]pyrrole-5-carbonyl chloride

Molecular Formula:C₇H₄ClNOS

Molecular Weight:185.63100

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:347.9ºC at 760mmHg

Density:1.576g/cm3

Index of Refraction:1.733

PSA:61.10000

Exact Mass:184.97000

LogP:2.60840

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 4h-thieno[3,2-b]pyrrole-5-carbonyl chloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4h-thieno[3,2-b]pyrrole-5-carbonyl chloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4h-thieno[3,2-b]pyrrole-5-carbonyl chloride Use and application,4h-thieno[3,2-b]pyrrole-5-carbonyl chloride technical grade,usp/ep/jp grade.

Related News: Under the plan, nonessential hospital staff members who belong to the union would not go to work on Monday. 4h-thieno[3,2-b]pyrrole-5-carbonyl chloride manufacturer Human iPSCs possess the unique dual properties of unlimited self-renewal and differentiation potential into all cell types of the body. 4h-thieno[3,2-b]pyrrole-5-carbonyl chloride supplier Human iPSCs possess the unique dual properties of unlimited self-renewal and differentiation potential into all cell types of the body. 4h-thieno[3,2-b]pyrrole-5-carbonyl chloride vendor The entire set of results “strongly support” the Darzalex-Rd combo as a new standard of care for newly diagnosed, transplant-ineligible multiple myeloma patients, Thierry Facon, M.D., an investigator of the MAIA trial, said in a statement. 4h-thieno[3,2-b]pyrrole-5-carbonyl chloride factory The entire set of results “strongly support” the Darzalex-Rd combo as a new standard of care for newly diagnosed, transplant-ineligible multiple myeloma patients, Thierry Facon, M.D., an investigator of the MAIA trial, said in a statement.